XML 19 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Theravance Respiratory Company, LLC (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2019
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2019
USD ($)
item
Sep. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Theravance Respiratory Company, LLC              
Income (Loss) from Equity Method Investments   $ 7,197 $ 3,119 $ 21,792 $ 5,754    
Amounts due from TRC, LLC   16,661   $ 16,661     $ 5,422
Arbitration against Innoviva and TRC              
Theravance Respiratory Company, LLC              
Amount of distribution withheld   6,900          
Partial dsitribution received   $ 10,600          
Amounts due from TRC, LLC           $ 20,000  
TRC              
Theravance Respiratory Company, LLC              
Percentage of equity interest   85.00%   85.00%      
Percentage of economic interest       85.00%      
Number of fiscal quarters | item       4      
Equity method investments   $ 16,700   $ 16,700     $ 5,400
Royalty payments   7,200 $ 3,100 21,800 $ 5,800    
Royalty expenses       2,300      
Amounts due from TRC, LLC   16,700   16,700      
TRC | Arbitration against Innoviva and TRC              
Theravance Respiratory Company, LLC              
Percentage of economic interest 85.00%            
Amount of distribution withheld   $ 8,000   $ 8,000